openPR Logo
Press release

Lawsuit filed for Investors who lost money with shares of MicroStrategy Incorporated (NASDAQ: STRK)

A lawsuit was filed on behalf of investors in MicroStrategy Incorporated (NASDAQ: STRK) shares.

A lawsuit was filed on behalf of investors in MicroStrategy Incorporated (NASDAQ: STRK) shares.

An investor, who purchased shares of MicroStrategy Incorporated (NASDAQ: STRK), filed a lawsuit over alleged violations of Federal Securities Laws by MicroStrategy Incorporated d/b/a Strategy.

Investors who purchased shares of MicroStrategy Incorporated (NASDAQ: STRK) have certain options and for certain investors are short and strict deadlines running. Deadline: July 15, 2025. NASDAQ: STRK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Tyson Corner, VA based MicroStrategy Incorporated, together with its subsidiaries, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally.

Since 2020, MicroStrategy Incorporated has increasingly focused on purchasing and holding bitcoin, a type of crypto-currency, as a long-term business strategy.

In October 2023, this strategy became so central to the Company's operations that it began referring to itself as a "Bitcoin Treasury Company" that primarily uses proceeds from equity and debt financings, as well as cash flows from its operations, to accumulate bitcoin, which serves as its primary treasury reserve asset.

MicroStrategy Incorporated (NASDAQ: STRK) reported that its annual Total Revenue declined from $496.26 million in 2023 to $463.45 million in 2024, and that its Net Income of $429.12 milion in 2023 turned to a Net Loss of over $1.16 billion in 2024.

On January 1, 2025, MicroStrategy Incorporated adopted the Financial Accounting Standards Board's ("FASB") Accounting Standards Update No. 2023-08, Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets ("ASU 2023-08"). ASU 2023-08 requires publicly traded companies to measure their crypto assets at fair value in their financial statements, with gains and losses from changes in the fair value of those assets recognized in net income in each reporting period. The FASB issued ASU 2023-08 to improve the way that companies account for their crypto assets and, accordingly, require them to provide a more accurate assessment of the fair value of those assets.
Prior to its adoption of ASU 2023-08, rather than employing a fair value accounting methodology, MicroStrategy Incorporated accounted for its bitcoin under a cost-less-impairment accounting model, whereby the Company classified its large bitcoin holdings as intangible assets. Under this accounting model, Strategy only needed to recognize impairments in the event of price depreciations and would not mark up for price increases unless the assets were sold.

On April 7, 2025, MicroStrategy Incorporated disclosed in a filing with the United States Securities and Exchange Commission that, following its adoption of ASU 2023-08, it recognized a $5.91 billion unrealized loss on its digital assets for the first quarter of 2025, which was expected to result in a net loss for the quarter. As a result, Strategy warned investors that "[w]e may not be able to regain profitability in future periods, particularly if we incur significant unrealized losses related to our digital assets."

Then, on May 1, 2025, MicroStrategy Incorporated announced its financial results for the first quarter of 2025. Therein, the Company confirmed that it had recorded an unrealized fair value loss on digital assets of approximately $5.9 billion during the quarter. On a subsequent earnings call to discuss these results, Company management explained that this loss stemmed from applying a fair value accounting methodology to Strategy's bitcoin assets following bitcoin's steep depreciation in value in the first quarter of 2025.

Shares of MicroStrategy Incorporated (NASDAQ: STRK) declined from $100.25 per share on February 19, 2025, to $79.40 per share on April 09, 2025.

The plaintiff claims that between April 30, 2024 and April 4, 2025, the Defendants made false and/or misleading statements and/or failed to disclose that the anticipated profitability of the Company's bitcoin-focused investment strategy and treasury operations was overstated, that the various risks associated with bitcoin's volatility and the magnitude of losses Strategy could recognize on the value of its digital assets following its adoption of ASU 2023-08 were understated, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of MicroStrategy Incorporated (NASDAQ: STRK) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of MicroStrategy Incorporated (NASDAQ: STRK) here

News-ID: 4041334 • Views:

More Releases from Shareholders Foundation, Inc.

Investors who lost money with shares of Organon & Co. (NYSE: OGN) should contact the Shareholders Foundation in connection with pending Lawsuit
Investors who lost money with shares of Organon & Co. (NYSE: OGN) should contact …
An investor, who purchased shares of Organon & Co. (NYSE: OGN), filed a lawsuit over alleged violations of Federal Securities Laws by Organon & Co in connection with certain allegedly false and misleading statements. Investors who purchased shares of Organon & Co. (NYSE: OGN) have certain options and for certain investors are short and strict deadlines running. Deadline: July 22, 2025. NYSE: OGN investors should contact the Shareholders Foundation at
Investigation announced for Long-Term Investors in shares of The Bancorp, Inc. (NASDAQ: TBBK) Long over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of The Bancorp, Inc. ( …
An investigation was announced for long-term investors in shares of The Bancorp, Inc. (NASDAQ: TBBK) concerning potential breaches of fiduciary duties by certain directors of The Bancorp, Inc. Investors who are current long term investors in The Bancorp, Inc. (NASDAQ: TBBK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Investors who lost money with shares of Krispy Kreme, Inc. (NASDAQ: DNUT) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Krispy Kreme, Inc. (NASDAQ: DNUT) should …
An investor, who purchased shares of Krispy Kreme, Inc. (NASDAQ: DNUT), filed a lawsuit over alleged violations of Federal Securities Laws by Krispy Kreme, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Krispy Kreme, Inc. (NASDAQ: DNUT) have certain options and for certain investors are short and strict deadlines running. Deadline: July 15, 2025. NASDAQ: DNUT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)
Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutic …
An investor, who purchased shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), filed a lawsuit i over alleged violations of Federal Securities Laws by Iovance Biotherapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) have certain options and for certain investors are short and strict deadlines running. Deadline: July 14, 2025. NASDAQ: IOVA investors should contact the Shareholders Foundation at

All 5 Releases


More Releases for Strategy

Business Growth Marketing Strategy, Effective Market Strategy to Improve Operati …
A Business Growth Marketing Strategy is a plan of action that empowers you to obtain a larger level of market share than you at the moment have. Contrary to prominent belief, an international marketing entry strategy is not necessarily focused on the short-term earnings; growth strategies can be long-term, too. A Winning Market Entry Strategy has an impression commonly on the number of consumers you have and your revenue. If
Business Growth and Winning Marketing Strategy | Effective Strategy to Improve O …
If you have your both the eyes on a new market. You're assured your product or services are a perfect. But to get there, you will foremost desire to advance a strategy. A Business Growth Marketing Strategy is a primary tool for clarifying what you aim to attain and how you are going to attain it when inflowing a new market. While an export schedule tends to purpose on just
Singapore Market Entry Strategy, Business Growth Marketing Strategy, Market Entr …
The market entry strategy is a plan’s distribution and delivery method of goods and services to a new target market. In the import and export of services, it symbolizes to the generation, expansions and the management of the contracts in a foreign region. In other words, for intensifying the business in a new region of by originating a fresh product or service line, you actively desire a winning market entry
Growth Strategy Market Report, International Expansion Strategy: Ken Research
The market expansion is a business growth strategy. Corporates implement a market expansion strategy when their growth peaks across the prevailing channels. Success reliant on confirming that they fulfilled prevailing markets. Corporates must then recognize other markets that are convenient to reach. Corporates reconnoitering potential markets must take stock of their abilities and assets. These may involve the fresh and prevailing products with an appeal in untapped locations. Ken research is
Customer Experience Strategy Market Is Thriving Worldwide with Major Eminent Pla …
An exclusive Customer Experience Strategy Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Customer Experience Strategy Market By Type, By Application, By Region - United States, EU, Japan, China, India, Southeast Asia. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report
Global HIV Diagnosis Market Strategy, Brand Strategy, Target Client and Forecast …
Data Bridge Market Research provides new industry report "HIV diagnosis market" accounted to USD 2.25 billion in 2016 growing at a CAGR of 10.4% during the forecast period of 2017 to 2024. “Global HIV Diagnosis Market" Report, By Product Type (Consumables, Assay, Kits, and Reagents, Other Consumables, Instruments, Software and Services), By Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent,